Cargando…
Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study
INTRODUCTION: Metformin has anti-inflammatory and anti-thrombotic effects that may improve the outcome of critical illness, but clinical data are limited. We examined the impact of preadmission metformin use on mortality among intensive care unit (ICU) patients with type 2 diabetes. METHODS: We cond...
Autores principales: | Christiansen, Christian Fynbo, Johansen, Martin Berg, Christensen, Steffen, O’Brien, James M, Tønnesen, Else, Sørensen, Henrik Toft |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057514/ https://www.ncbi.nlm.nih.gov/pubmed/24018017 http://dx.doi.org/10.1186/cc12886 |
Ejemplares similares
-
Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study
por: Christensen, Steffen, et al.
Publicado: (2011) -
Preadmission statin use and one-year mortality among patients in intensive care - A cohort study
por: Christensen, Steffen, et al.
Publicado: (2010) -
One-year mortality among Danish intensive care patients with acute kidney injury: a cohort study
por: Gammelager, Henrik, et al.
Publicado: (2012) -
Three-year risk of cardiovascular disease among intensive care patients with acute kidney injury: a population-based cohort study
por: Gammelager, Henrik, et al.
Publicado: (2014) -
Five-year risk of end-stage renal disease among intensive care patients surviving dialysis-requiring acute kidney injury: a nationwide cohort study
por: Gammelager, Henrik, et al.
Publicado: (2013)